Rob Chisholm is an accomplished biopharmaceutical executive with over 25 years of global industry experience, specializing in bringing innovative therapies to market for patients with serious medical conditions. He has held senior leadership roles at leading companies including Takeda, Kyowa Kirin, GSK, IQVIA, and Astellas, where he successfully navigated the strategic and operational challenges of drug development and commercialization. Rob is the Founder and CEO of Noveeda, a consultancy focused on accelerating biotech innovation. As Chief Business Officer at Nimverta, he brings deep industry insight, a broad global network, and a proven track record of guiding startups through growth and market entry.